Form 4: Teladoc Health Executive Acquires 40,800 Restricted Stock Units
SEC Form 4 Filing
Daniel Trencher, Chief Strategy Officer of Teladoc Health, reports the acquisition of 40,800 restricted stock units.
Summary
- Daniel Trencher, Chief Strategy Officer of Teladoc Health, acquired 40,800 restricted stock units on March 19, 2024.
- These restricted stock units represent a contingent right to receive one share of Teladoc Health common stock each.
- One-third of the restricted stock units will vest on the first anniversary of the grant date.
- The remaining units will vest in eight substantially equal quarterly installments starting on June 1, 2025.
- Following the transaction, Trencher directly owns 40,800 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to executive compensation, and does not inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of executive compensation in the form of restricted stock units, a common practice in publicly traded companies to align executive interests with shareholder value.
Stakeholder Impact
- The vesting of restricted stock units aligns the executive's interests with those of the shareholders, incentivizing long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of transaction: acquisition of restricted stock units |
| 03/20/2024 | Date of Form 4 filing |
| June 1, 2025 | Start date for quarterly vesting installments |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.